poc hba1c testing market trends, poc hba1c testing market outlook, poc hba1c testing market forecast, point-of-care hba1c testing market, poc hba1c testing market overview, poc hba1c testing market analysis
At what pace is the poc hba1c testing market growing, and what is its estimated value?
The Poc Hba1C testing market size has grown rapidly in recent years. It will grow from $0.92 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to strong economic growth in emerging markets, an increase in diabetes prevalence, a rise in COVID-19 cases, and an increase in disposable income.
The Poc Hba1C testing market size is expected to see rapid growth in the next few years. It will grow to $1.62 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to rising government support, increasing prevalence of diabetes- type ii diabetes, easy accessibility of POC tests, and faster availability of results in POC testing than conventional laboratory testing procedures. Major trends in the forecast period include a focus on hba1c microfluidic immunofluorescence test, increasing use of home collection hba1c testing kits, focus on the hba1c test using capillary electrophoresis technology, and advances in testing technologies.
Get Your Free Sample of The Global Poc Hba1C Testing Market Report:
What are the top drivers to the rising demand in the poc hba1c testing market?
The increasing prevalence of diabetes is expected to propel the growth of the POC HbA1C testing market. Long working hours, less physical activity, and unhealthy eating and drinking habits are increasing the prevalence of diabetes. Diabetes can be diagnosed and monitored with point-of-care (POC) HbA1c assays, which can be utilized in community settings and healthcare facilities without laboratories. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the increasing prevalence of diabetes is driving the growth of the POC hba1c testing market.
How is the poc hba1c testing market segmented?
The Poc Hba1C testing market covered in this report is segmented –
1) By Type of Product: Instruments, Consumables
2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies
3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users
Subsegments:
1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems
2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices
Order your report now for swift delivery
Who are the top competitors in the poc hba1c testing market?
Major companies operating in the Poc Hba1C testing market include F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS, Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech, Inc, Alere Inc, bioMerieux, EKF Diagnostics, HemoCue, PTS Diagnostics, Diazyme Laboratories, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Medtronic PLC, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation, B Braun Melsungen AG.
What significant trends should we anticipate in the poc hba1c testing market over the forecast period?
Technological advances are a key trend gaining popularity in the POC HbA1C testing market. Major players in the market are investing in developing advanced technologies to provide fast, accurate results in a short period thereby helping laboratories to manage the increase in demand for testing. For instance, Abbott, a US-based medical devices and health care company, introduced Afinion HbA1c Dx assay, an in vitro diagnostic test for the quantitative determination of HbA1c in human venous and capillary whole blood for use on the Afinion 2 Analyzer, and also Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the only rapid POC test cleared by the U.S. Food and Drug Administration (FDA) to assist healthcare professionals in diagnosing diabetes and determining the patient’s risk of developing the disorder. The test provides reliable and accurate results of 1,2 glycated hemoglobin in just three minutes, helping physicians evaluate patients and enabling them to formulate individualized care plans during a single visit to the doctor`s office.
Which regional trends are influencing the poc hba1c testing market, and which area dominates the industry?
The countries covered in the POC hba1c testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
What Does The Poc Hba1C Testing Market Report 2025 Offer?
The poc hba1c testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
POC HbA1C testing devices are designed to diagnose average levels of glucose in patients’ blood and to control type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. This assesses the average level of blood sugar over 2 to 3 months in an individual.
Purchase the exclusive report now to unlock valuable market insights:
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
